We are pleased to announce that Sean Tunis, MD, MSc, will join the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center as its first Senior Fellow.
As a Senior Fellow, Dr. Tunis will serve as an advisor to CEVR on various projects related to the assessment and valuation of drugs, devices, procedures, and public health programs. He will also advise on CEVR’s policy initiatives, including work with the Institute for Clinical and Economic Research (ICER), evaluations of health technology assessment (HTA) organizations worldwide, and input into CEVR databases, including the Specialty Drug Coverage and Evidence (SPEC) database. Dr. Tunis will continue to reside in Baltimore and will serve in this role on a part-time basis. His role with CEVR begins immediately.
Dr. Tunis has a long and distinguished career in health policy. He served as a member of Senator Ted Kennedy’s staff in the US Senate, working on legislation on orphan drugs, FDA user fees, and the reauthorization of the Agency for Healthcare Research and Quality. He then headed the health program at the Congressional Office of Technology Assessment and served as Chief Medical Officer of the Center for Medicare & Medicaid Services from 2000 to 2005. He founded the Center for Medical Technology Policy (CMTP) in Baltimore and served as CMTP’s CEO from 2006-2019. Dr. Tunis received his medical degree and Masters in Health Services Research from the Stanford University School of Medicine, and a BS degree in Biology and History of Science from Cornell.
“We are thrilled to welcome Sean to CEVR in this capacity,” said Peter Neumann, CEVR’s director. He has been at the forefront of evidence-based medicine and HTA issues for decades and we look forward to his input and wise counsel on a host of topics.”
